The advent of anti-vascular endothelial growth factor (VEGF) designed for intraocular injection has revolutionised the treatment of neovascular age-related macular degeneration (nAMD), the leading ...

An AI segmentation system was able to identify changes in retinal segmented features based on optical coherence tomography (OCT) images. Diagnosing and monitoring retinal diseases is done through OCT, ...

Diabetic retinopathy (DR) is a leading cause of blindness among working-age adults, affecting more than 130 million people worldwide. Although advances in ophthalmic imaging have improved disease ...

Due to an aging population, visual impairment from neovascular age-related macular degeneration (nAMD) is increasing in the United States. Despite unprecedented improvements in vision preservation ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Vabysmo ...

‒ Post-hoc analyses from four Phase III studies indicate Vabysmo dried retinal fluid faster with fewer injections in wet age-related macular degeneration (AMD) and diabetic macular edema (DME) – ‒ ...

In this interview, industry expert Dr. Yifan Jian discusses advancements in ultrawide-field optical coherence tomography (OCT), challenges in retinal imaging, AI’s role in biophotonics, and the future ...

Regular eye exams are important in detecting early signs of diabetic retinopathy to prevent vision loss. Since diabetic retinopathy doesn’t cause symptoms in its early stages, diagnostic testing can ...